Intralytix, Inc.

Microbiome research is generating huge amounts of data on the presence and proliferation of microbes in the gastrointestinal tract and elsewhere in the body, and the desire to apply this data to the d

There may be some early wins when applying new thinking about the microbiome to novel approaches to therapy, but it’s going to take time to link insights into the microbial flora with disease and to c

Ferring Pharmaceuticals AS expects to start a proof-of-principle clinical study of a bacteriophage cocktail in the U.S. later this year for inflammatory bowel disease, targeting a fledgling therapeu

Fighting antibiotic-resistant infections with a bacteriophage-delivered protein. Researchers first began exploring the use of bacteriophage to fight bacterial infection over 80 years ago. Bacteriophag